Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
15,4 USD | -0,16% |
|
-10,88% | -33,87% |
04/06 | CARGO Therapeutics, Inc. kondigt de benoeming aan van Jane Pritchett Henderson als onafhankelijk bestuurder | CI |
15/05 | CARGO THERAPEUTICS, INC. : Een koopadvies van Truist Securities | ZM |
Vakgebied
Aantal werknemers: 123
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gina Chapman
CEO | Chief Executive Officer | 57 | 01-05-22 |
Director of Finance/CFO | 44 | 01-08-22 | |
Michael Ports
CTO | Chief Tech/Sci/R&D Officer | 43 | 01-08-23 |
Shishir Gadam
CTO | Chief Tech/Sci/R&D Officer | 56 | 01-01-22 |
Ginna Laport
CTO | Chief Tech/Sci/R&D Officer | 59 | 17-10-23 |
Chief Tech/Sci/R&D Officer | - | 01-07-23 | |
39 | - | ||
Kari E. Leetch
HRO | Human Resources Officer | - | 01-07-23 |
Halley Gilbert
LAW | General Counsel | 54 | 01-08-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Lubner
BRD | Director/Board Member | 60 | 01-07-23 |
John Orwin
CHM | Chairman | 59 | 01-09-22 |
Gina Chapman
CEO | Chief Executive Officer | 57 | 01-05-22 |
Kapil Dhingra
BRD | Director/Board Member | 64 | 15/04 |
Reid Huber
BRD | Director/Board Member | 52 | 01-03-23 |
Director/Board Member | 45 | 01-10-22 | |
Abraham Bassan
BRD | Director/Board Member | 39 | 01-02-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 45 846 963 | 42 856 735 ( 93,48 %) | 0 | 93,48 % |
Bedrijfsgegevens
![Adres CARGO Therapeutics, Inc.(CRGX)](https://cdn.zonebourse.com/static/address/161690270.png)
Sector
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-33,87% | 608 mln. | |
+36,15% | 51,07 mld. | |
-7,93% | 38,78 mld. | |
+35,17% | 38,61 mld. | |
-8,98% | 27,32 mld. | |
+11,76% | 26,35 mld. | |
-19,12% | 19,46 mld. | |
+40,65% | 13,58 mld. | |
+30,25% | 12,46 mld. | |
-3,93% | 11,75 mld. |
- Beurs
- Aandelen
- Koers CRGX
- Onderneming CARGO Therapeutics, Inc.